|
|
|
|
Search: 
Latin American Herald Tribune
Venezuela Overview
Venezuelan Embassies & Consulates Around The World
Sites/Blogs about Venezuela
Venezuelan Newspapers
Facts about Venezuela
Venezuela Tourism
Embassies in Caracas

Colombia Overview
Colombian Embassies & Consulates Around the World
Government Links
Embassies in Bogota
Media
Sites/Blogs about Colombia
Educational Institutions

Stocks

Commodities
Crude Oil
US Gasoline Prices
Natural Gas
Gold
Silver
Copper

Euro
UK Pound
Australia Dollar
Canada Dollar
Brazil Real
Mexico Peso
India Rupee

Antigua & Barbuda
Aruba
Barbados
Cayman Islands
Cuba
Curacao
Dominica

Grenada
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines

Belize
Costa Rica
El Salvador
Honduras
Nicaragua
Panama

Bahamas
Bermuda
Mexico

Argentina
Brazil
Chile
Guyana
Paraguay
Peru
Uruguay

What's New at LAHT?
Follow Us On Facebook
Follow Us On Twitter
Most Viewed on the Web
Popular on Twitter
Receive Our Daily Headlines


  HOME | USA

Trump to Stop Taking Hydroxychloroquine in ‘a Day or Two’

WASHINGTON – President Donald Trump said on Wednesday that he will soon complete his course of hydroxychloroquine, an anti-malaria drug he started taking to ward off coronavirus despite a lack of evidence it has any effect on a disease that has killed more than 93,000 people in the United States and nearly 326,000 worldwide.

“I think the regimen finishes in a day or two. I think it’s in two days,” he told reporters at the White House.

Trump revealed on Monday that he began taking a combination of hydroxychloroquine and zinc two weeks ago as a preventative measure.

The drug has long been used to treat illnesses such as malaria, lupus and severe arthritis. As the coronavirus spread across the world, some doctors turned to hydroxychloroquine, though usually only as a last resort.

Clinical trials of hydroxychloroquine as a treatment for COVID-19 are still in progress and it remains unclear whether it has any value as a prophylactic for the disease or in hastening recovery for people infected with the virus.

The president had already drawn criticism from the medical community for touting the effectiveness of hydroxychloroquine against COVID-19 and the negative reaction intensified once he disclosed he was taking the drug.

“I think it’s worthwhile as a line of defense, and I plan on staying on it for a little while longer,” Trump said Wednesday. “I’m just very curious myself.”

He emphasized that he had not noticed any negative side-effects from the medication, which, according to a US Food and Drug Administration (FDA) warning issued last month, can cause severe heart problems.

A study published at the end of April in the International Journal of Rheumatic Diseases said there was insufficient evidence to support the claim that hydroxychloroquine can prevent infection with the coronavirus.

The Senate heard testimony last week from Dr. Rick Bright, a vaccine expert who claimed he was demoted from his position in the Department of Health and Human Services because he voiced concerns about the president’s promotion of hydroxychloroquine as a COVID-19 treatment.

Trump’s praise for the drug has also made it difficult for lupus and arthritis sufferers to obtain hydroxychloroquine.

The US remains by far the global center of the pandemic, with 1.5 million confirmed cases.

 

Enter your email address to subscribe to free headlines (and great cartoons so every email has a happy ending!) from the Latin American Herald Tribune:

 

Copyright Latin American Herald Tribune - 2005-2020 © All rights reserved